Penn Medicine | Strategic Alliance Partners
Penn Medicine is one of the world’s leading academic medical centers, dedicated to the related missions of medical education, biomedical research, excellence in patient care, and community service. The organization consists of the University of Pennsylvania Health System and Penn’s Raymond and Ruth Perelman School of Medicine, founded in 1765 as the nation’s first medical school. Home to a proud history of “firsts” in medicine, Penn Medicine teams have pioneered discoveries and innovations that have shaped modern medicine, including recent breakthroughs such as CAR T cell therapy for cancer.
Collaboration is, and always has been, a cornerstone of Penn Medicine’s approach to groundbreaking research and quality care. Penn Medicine’s comprehensive cancer system includes the Abramson Cancer Center and Roberts Proton Therapy Center in Philadelphia, the Ann B. Barshinger Cancer Institute, Penn Medicine Princeton Cancer Center, and proton therapy center in Lancaster, the Penn Medicine | Virtua Health Proton Therapy Center in South New Jersy, and dozens of outpatient multispecialty care locations that stretch from the Susquehanna River in Pennsylvania to the New Jersey shore.
The Abramson Cancer Center has proudly been NCI-Designated Comprehensive since 1973. The Abramson Cancer Center is one of a select group of cancer centers in the country awarded the prestigious designation of Comprehensive Cancer Center by the National Cancer Institute. This status, which has been awarded to the Abramson Cancer Center continuously for the past 47 years, reflects our outstanding research, clinical services, education and information services and community outreach.
